DK455274A - - Google Patents

Info

Publication number
DK455274A
DK455274A DK455274A DK455274A DK455274A DK 455274 A DK455274 A DK 455274A DK 455274 A DK455274 A DK 455274A DK 455274 A DK455274 A DK 455274A DK 455274 A DK455274 A DK 455274A
Authority
DK
Denmark
Application number
DK455274A
Other languages
Danish (da)
Other versions
DK155173B (da
Inventor
G Dahlhausen
H-W Dibbern
W Fylberth
G Ross
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5890849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK455274(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK455274A publication Critical patent/DK455274A/da
Publication of DK155173B publication Critical patent/DK155173B/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK455274AA 1973-08-28 1974-08-27 Fremgangsmaade til fremstilling af praeparater af n-(2-furfuryl)-4-chlor-5-sulfamoyl-anthranilsyre med forsinket frigoerelse DK155173B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2343218 1973-08-28
DE2343218A DE2343218C2 (de) 1973-08-28 1973-08-28 Furosemid enthaltende Pellets

Publications (2)

Publication Number Publication Date
DK455274A true DK455274A (es) 1975-04-28
DK155173B DK155173B (da) 1989-02-27

Family

ID=5890849

Family Applications (1)

Application Number Title Priority Date Filing Date
DK455274AA DK155173B (da) 1973-08-28 1974-08-27 Fremgangsmaade til fremstilling af praeparater af n-(2-furfuryl)-4-chlor-5-sulfamoyl-anthranilsyre med forsinket frigoerelse

Country Status (17)

Country Link
US (1) US4324779A (es)
JP (1) JPS563849B2 (es)
AT (1) AT344914B (es)
BE (1) BE819294A (es)
CA (1) CA1063024A (es)
DE (1) DE2343218C2 (es)
DK (1) DK155173B (es)
EG (1) EG14662A (es)
FI (1) FI249774A (es)
FR (1) FR2242076B1 (es)
GB (1) GB1478715A (es)
HU (1) HU171769B (es)
IL (1) IL45521A (es)
MX (1) MX3585E (es)
NL (1) NL7411269A (es)
SE (1) SE7410788L (es)
ZA (1) ZA745443B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI65910C (fi) * 1976-11-26 1984-08-10 Pennwalt Corp Foerfarande foer framstaellning av farmaceutiska preparat med laongtidsverkan
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4773907A (en) * 1982-12-20 1988-09-27 Alza Corporation Primary delivery system comprising secondary dosage form
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
DE3305935C2 (de) * 1983-02-21 1985-05-30 Medice Chem.-Pharm. Fabrik Pütter GmbH & Co KG, 5860 Iserlohn Kaliumneutrales Saluretikum mit antihypertensiver Wirkung
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
US4663348A (en) * 1985-07-02 1987-05-05 Warner-Lambert Co. Furosemide salts and pharmaceutical preparations thereof
SE460947B (sv) * 1986-08-26 1989-12-11 Lejus Medical Ab En multiple-unit-dos komposition av l-dopa
JPH01130957U (es) * 1988-02-29 1989-09-06
JPH0710747A (ja) * 1993-04-28 1995-01-13 Takeda Chem Ind Ltd 固形製剤およびその製造方法
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
US20070059358A1 (en) * 2003-07-02 2007-03-15 Tianjin Tasly Pharmaceutical Co., Ltd., China Matrix adjuvants and the drop pills prepared with them

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3361632A (en) * 1964-05-08 1968-01-02 Hoechst Ag Medicinal preparations having a protracted activity and method of making them
US3456049A (en) * 1965-05-25 1969-07-15 Ciba Geigy Corp Gradual-release tablet
US3857933A (en) * 1969-10-17 1974-12-31 Hoechst Ag Process for the manufacture of a drug dosage form permitting controlled release of active ingredient
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung

Also Published As

Publication number Publication date
SE7410788L (es) 1975-03-03
CA1063024A (en) 1979-09-25
IL45521A (en) 1978-07-31
US4324779A (en) 1982-04-13
AT344914B (de) 1978-08-25
FR2242076B1 (es) 1978-07-28
ATA694274A (de) 1977-12-15
DK155173B (da) 1989-02-27
IL45521A0 (en) 1974-11-29
JPS5076217A (es) 1975-06-21
MX3585E (es) 1981-03-20
NL7411269A (nl) 1975-03-04
DE2343218A1 (de) 1975-04-03
EG14662A (en) 1984-09-30
AU7272874A (en) 1976-03-04
HU171769B (hu) 1978-03-28
GB1478715A (en) 1977-07-06
JPS563849B2 (es) 1981-01-27
FR2242076A1 (es) 1975-03-28
FI249774A (es) 1975-03-01
BE819294A (fr) 1975-02-28
ZA745443B (en) 1975-08-27
DE2343218C2 (de) 1986-08-07

Similar Documents

Publication Publication Date Title
AR201758A1 (es)
AU476761B2 (es)
AU465372B2 (es)
AR201235Q (es)
AR201231Q (es)
AU474593B2 (es)
AU474511B2 (es)
AU474838B2 (es)
AU465453B2 (es)
AU471343B2 (es)
AU450229B2 (es)
FR2242076B1 (es)
AU476714B2 (es)
AR201229Q (es)
AU466283B2 (es)
AU472848B2 (es)
AU476696B2 (es)
AR199451A1 (es)
AR195311A1 (es)
AR197627A1 (es)
AU447540B2 (es)
AR210729A1 (es)
AU461342B2 (es)
AR201432A1 (es)
AR200885A1 (es)

Legal Events

Date Code Title Description
PRF Application refused